10-Q: Pyxus Q3 Earnings Plunge Amidst Sales Decline, Rising Debt

Pyxus International reports a significant drop in third-quarter and year-to-date net income and sales, driven by lower leaf product volumes and increased operational costs, despite improved gross margin percentage.

Summary

• Sales and other operating revenues decreased by 15.7% to $655.8 million for the three months ended December 31, 2025, compared to $778.3 million in the prior year.
• Net income attributable to Pyxus International, Inc. fell by 10.6% to $16.9 million for the quarter, and by 99.0% to $0.2 million for the nine months ended December 31, 2025.
• Basic and diluted earnings per share decreased to $0.65 for the quarter and $0.01 for the nine months, down from $0.74 and $0.79 respectively in the prior year periods.
• Gross profit as a percentage of sales slightly increased to 15.2% for the quarter and 14.6% year-to-date, attributed to a favorable product mix and strong processing volumes.
• Income from unconsolidated affiliates significantly increased by 188.4% to $12.4 million for the quarter, primarily due to higher profitability in South America and gains in Asia.
• Net cash used in operating activities substantially increased to $(518.6) million for the nine months ended December 31, 2025, compared to $(171.7) million in the prior year.
• Net debt rose to $1,159.4 million as of December 31, 2025, from $960.0 million as of December 31, 2024, driven by higher borrowings for inventory purchases.
• Total processed and unprocessed tobacco inventories remained elevated at $959.8 million as of December 31, 2025, reflecting larger crop volumes from Africa and South America.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a challenging quarter with significant declines in sales and profitability, increased debt, and substantial cash outflow from operations, despite some operational efficiencies and improved affiliate income. The outlook for potential oversupply in fiscal 2027 adds further pressure.

Positives

• Gross margin as a percent of sales improved to 15.2% for the three months ended December 31, 2025, from 15.0% in the prior year, and to 14.6% year-to-date from 13.9%, due to favorable product mix and strong processing volumes.
• Income from unconsolidated affiliates, net, increased significantly by 188.4% to $12.4 million for the quarter and 58.1% to $11.7 million year-to-date, driven by lower purchasing costs in South America and gains from asset sales and insurance recoveries in Asia.
• The company successfully completed its buying season and continues to meet customer leaf requirements.
• Elevated tobacco inventory levels of $959.8 million as of December 31, 2025, are expected to support ongoing customer demand and contribute to seasonally higher shipment activity in the remainder of the fiscal year.
• The ABL Credit Facility's aggregate revolving loan commitments increased to $150.0 million from $120.0 million, and its maturity was extended to May 12, 2030.
• Total borrowing capacity under foreign seasonal lines of credit increased by $183.8 million compared to the prior year, primarily utilized for purchasing larger volumes of green tobacco.
• Cash, cash equivalents, and restricted cash increased by $49.0 million for the nine months ended December 31, 2025.

Negatives

• Sales and other operating revenues decreased by 15.7% to $655.8 million for the three months ended December 31, 2025, and by 12.4% to $1,734.8 million for the nine months, primarily due to lower leaf product sales volumes and shifts in shipment timing.
• Net income attributable to Pyxus International, Inc. declined by 10.6% to $16.9 million for the quarter and by 99.0% to $0.2 million for the nine months ended December 31, 2025.
• Basic and diluted earnings per share decreased to $0.65 for the quarter and $0.01 for the nine months, down from $0.74 and $0.79 respectively in the prior year periods.
• Operating income decreased by 22.4% to $51.3 million for the quarter and by 14.8% to $119.0 million for the nine months.
• Income before income taxes and other items decreased by 54.5% to $15.1 million for the quarter and by 67.1% to $15.1 million for the nine months.
• Other expense, net, increased significantly by 131.6% to $8.8 million for the quarter and 43.3% to $13.9 million for the nine months, mainly due to the resolution of a discrete customs dispute and unfavorable foreign currency fluctuations.
• Restructuring and asset impairment charges increased to $1.5 million for the quarter and $1.6 million for the nine months, up from $0.1 million and $0.4 million respectively.
• Interest expense, net, increased by 11.2% to $36.6 million for the quarter and 2.4% to $104.3 million for the nine months.
• The prior year included an $8.2 million gain on debt retirement, which did not recur in the current nine-month period.
• Net cash used in operating activities increased substantially to $(518.6) million for the nine months ended December 31, 2025, from $(171.7) million in the prior year.
• Net debt increased to $1,159.4 million as of December 31, 2025, from $960.0 million as of December 31, 2024, due to higher borrowings on foreign seasonal lines of credit.
• The current ratio declined to 1.3 to 1 as of December 31, 2025, from 1.4 to 1 in the prior year.
• Early indications for the upcoming crop season suggest continued strong production, which is expected to result in oversupply levels at the beginning of fiscal 2027, potentially impacting future pricing and sales.

Risks

• Reliance on a small number of significant customers and continued vertical integration by customers.
• Global shifts in sourcing customer requirements, imposition of tariffs, and other changes in international trade policies.
• Shifts in the global supply and demand position for tobacco products, including potential oversupply in fiscal 2027.
• Variation in financial results due to growing conditions, customer indications, and other factors.
• Loss of confidence by customers, farmers, and other suppliers, and migration of suppliers to other crops.
• Risks related to the advancement of inputs to tobacco suppliers and the quality/quantity of purchased tobacco.
• Weather and other environmental conditions affecting inventory quantity and marketability.
• International business risks, including unsettled political conditions, uncertainty in legal enforcement, fraud, expropriation, import/export restrictions, exchange controls, inflationary economies, currency risks, and restrictions on repatriation of earnings.
• High risk of potential violations of the Foreign Corrupt Practices Act in many operating jurisdictions.
• Risks and uncertainties related to geopolitical conflicts, including the Middle East and shipping disruptions, and impacts of international sanctions.
• Exposure to foreign tax regimes with unclear, inconsistently applied, and suddenly changing rules.
• Fluctuations in foreign currency exchange and interest rates.
• Competition with other primary global independent leaf tobacco merchants.
• Disruption, failure, or security breaches of information technology systems and other cybersecurity risks.
• Continued high inflation.
• Regulations regarding environmental matters.
• Risks related to the company's capital structure, including significant debt and ability to finance non-U.S. local operations with uncommitted short-term operating credit lines.
• Ability to continue to access capital markets to obtain long-term and short-term financing, and to refinance current credit facilities at favorable rates.
• Potential failure of foreign banks where subsidiaries maintain deposits or failure to transfer funds/honor withdrawals.
• Inability to generate sufficient cash to service indebtedness.
• Failure to achieve stated goals, which may adversely affect liquidity.
• Volatility and disruption of global credit markets.
• Failure by counterparties to derivative transactions to perform their obligations.
• Increasing scrutiny and changing expectations from governments and stakeholders regarding environmental, social, and governance policies.
• Inherent risk of exposure to product liability claims, regulatory action, and litigation for e-liquid and consumable nicotine products manufactured and supplied by joint ventures.
• Certain shareholders (Glendon, Monarch, Owl Creek) have the ability to exercise controlling influence on various corporate matters.
• Reductions in demand for consumer tobacco products.
• Risks and uncertainties related to pandemics or other widespread health crises and any related shipping constraints, labor shortages, and supply-chain impacts.
• Legislative and regulatory initiatives that may reduce consumption of consumer tobacco products and demand for services, and increase regulatory burdens.
• Government actions that significantly affect tobacco sourcing, including crop diversification initiatives.
• Governmental investigations into the company's business activities, including leaf tobacco industry buying and other payment practices.
• Impact of proposed regulations to prohibit the sale of cigarettes and certain other tobacco products in the United States other than low-nicotine versions.
• A tax assessment from the Brazilian State of Parana totaling $10,595,000 (including penalties and interest) for intrastate trade tax credits, which if lost, would have a material impact on financial statements.

Future Outlook

The company's operations for the second half of fiscal year 2026 will focus on processing remaining current crop volumes and fulfilling customer shipments of processed tobacco. Higher inventory levels are expected to drive seasonally increased shipment activity. Early indications for fiscal year 2027 suggest continued strong production, which is anticipated to lead to oversupply conditions. The company expects to incur an additional $10.3 million in capital expenditures and $1.3 million in pension and postretirement benefit contributions for the remainder of fiscal year 2026. While liquidity sources are believed to be sufficient for the next twelve months, periods of high liquidity needs are anticipated, and plans to minimize cash outflows, including exiting non-cash-generating operations, may be undertaken if a deficiency arises.

Management Comments

• "The Company's third quarter results and working capital continue to reflect the impact of larger crops, a trend that has persisted throughout fiscal year 2026."
• "Operational and financial performance remains aligned with expectations, and after our successful buying season, the Company continues to support customers by ensuring their leaf requirements are met."
• "Larger crops led to improved performance in the Company's equity method investments, particularly in South America and Asia, resulting in higher income from unconsolidated affiliates in both the quarterly and year-to-date periods."
• "This higher inventory position will support ongoing customer demand and is anticipated to contribute to seasonally higher shipment activity in the remainder of the fiscal year."
• "Although we believe that our sources of liquidity will be sufficient to fund our anticipated operating needs for the next twelve months, we anticipate periods during which our liquidity needs for operations will approach the levels of our anticipated available cash and permitted borrowings under our credit facilities."

Industry Context

StockSavvy.ai notes that the global tobacco market is transitioning towards a more balanced supply environment in fiscal year 2026, moving away from prior years' undersupply conditions, largely due to increased crop volumes from Africa and South America. However, early forecasts for fiscal year 2027 indicate a potential shift to oversupply, which could impact pricing and market dynamics. The company's involvement in e-liquid and consumable nicotine products through joint ventures places it in an industry facing heightened regulatory scrutiny, health concerns, and product liability risks, which are significant trends across the broader nicotine product landscape.

Legal Proceedings

• A tax assessment from the Brazilian State of Parana, issued October 26, 2007, for intrastate trade tax credits, totaling $10,595,000 (including penalties and interest). The company intends to contest this, but a loss could have a material impact.
• Involvement in other litigation or legal matters incidental to business activities, including tax matters, which are being vigorously defended, with no current expectation of a material adverse effect, though an adverse resolution could be material.

Related Party Transactions

• Engaged in transactions with equity method investees for procuring and processing inventory, including sales of $20,564,000 and purchases of $150,754,000 for the nine months ended December 31, 2025.
• Received dividends of $7,022,000 from equity method investees for the nine months ended December 31, 2025.
• Significant shareholders Glendon Capital Management, L.P. (33.8% ownership), Monarch Alternative Capital LP (24.9% ownership), and Owl Creek Asset Management, L.P. (15.7% ownership) have representatives on the board or are investment managers of funds holding company debt.
• In the prior year, the company repurchased $77,922,000 of 2027 Notes for $60,000,000 and $10,345,000 of Pyxus Term Loans for $9,104,000 from Monarch-affiliated funds at a discount.
• In the prior year, the company repurchased 392,000 shares of its common stock for $1,000,000 from CI Investments, Inc., which was a beneficial owner of more than five percent of common stock at the time.
• Interest payable to Investor-Affiliated Funds was $1,373,000 as of December 31, 2025.
• Interest expense related to Investor-Affiliated Funds and CI Investments totaled $16,380,000 for the nine months ended December 31, 2025.

Stakeholder Impact

• Shareholders: Negative impact due to significant declines in net income and EPS, increased debt, and no cash dividends paid. The potential for oversupply in fiscal 2027 could further pressure share value.
• Customers: The company continues to support customers by meeting leaf requirements, and higher inventory levels are intended to ensure ongoing demand is met, despite some shipment timing shifts.
• Suppliers (farmers): Larger crop volumes indicate continued demand for their produce, but the risk of oversupply in fiscal 2027 could impact future pricing. Risks related to advances to tobacco suppliers remain.
• Creditors: Increased net debt and higher interest expense, though the company reports compliance with debt covenants. Reliance on short-term seasonal lines of credit highlights ongoing financing needs.
• Employees: Lower accrual for variable incentive compensation, but increased personnel costs. Restructuring charges may indicate some workforce adjustments.

Next Steps

• Focus on processing remaining current crop volumes and fulfilling customer shipments of processed tobacco during the second half of the fiscal year.
• Anticipate seasonally higher shipment activity in the remainder of the fiscal year, supported by higher inventory levels.
• Monitor and hedge foreign currency costs as needed.
• Evaluate the impact of new accounting standards (ASU 2025-06, ASU 2025-09, ASU 2025-10) on financial condition, results of operations, and cash flows.
• Potentially undertake plans to minimize cash outflows, including exiting operations that do not generate positive cash flow, to address potential liquidity deficiencies.
• Incur an additional $10.3 million in capital expenditures for the remainder of the fiscal year ending March 31, 2026.
• Make expected contributions of $1.3 million to pension and postretirement health and life insurance benefits for the remainder of the fiscal year.

Key Dates

Recommendation

The filing reveals a substantial deterioration in Pyxus International's financial performance, with significant year-over-year declines in sales, net income, and earnings per share for both the quarter and the nine-month period. The company's net cash used in operating activities has dramatically increased, and net debt has risen, indicating growing liquidity pressures. While gross margin percentage improved, it was insufficient to offset the revenue contraction. The non-recurrence of prior-year debt retirement gains further exposes underlying operational challenges. Furthermore, the outlook for potential oversupply in the tobacco market in fiscal 2027 suggests continued headwinds for the company's core business. Given these negative trends and the challenging market environment, a seasoned investor would likely recommend selling the stock.

Keywords

Tobacco, Leaf Agriculture, SEC Filing, 10-Q, Financial Results, Earnings, Revenue, Net Income, EPS, Debt, Inventory, Working Capital, Pyxus International, PYX, Foreign Currency, Capital Structure, Risk Factors, Corporate Governance, Related Party Transactions, Securitization, Brazil Tax Credits, E-liquids, Nicotine Products, Supply Chain